DarioHealth (NASDAQ:DRIO) is a digital health company that develops and operates a personalized chronic condition management platform. The company’s core offering combines a smartphone-based application, connected monitoring devices, and real-time data analytics designed to help people manage diabetes, hypertension and weight challenges. By integrating automated tracking, educational content and virtual coaching, DarioHealth aims to enable better patient engagement and improved clinical outcomes through behavioral insights and actionable feedback.
Through a subscription model, DarioHealth provides a suite of end-to-end solutions to consumers, employers, health plans and government agencies. Its product lineup includes a Bluetooth-enabled glucose meter, a blood pressure monitor, and a smart scale, all of which sync with the Dario app. Users can track key health metrics, receive tailored guidance from certified coaches, and share progress reports with healthcare providers. The platform’s data-driven approach is designed to identify trends, predict risk factors and drive long-term lifestyle changes.
Founded in 2014 and headquartered in New York, DarioHealth has expanded its reach across the United States, United Kingdom, Australia and New Zealand. The company secured regulatory clearances, including CE marking and U.S. Food and Drug Administration registration, for its monitoring devices. In 2020, DarioHealth became a publicly listed entity via a merger with a special purpose acquisition company, enabling it to accelerate product development and expand strategic partnerships with insurers, pharmacy benefit managers and large employer groups.
DarioHealth’s leadership team is led by Chief Executive Officer Elad Natanson, supported by executives with deep expertise in digital health, data science and healthcare operations. The company maintains research and development facilities in Israel and the U.S., where multidisciplinary teams work on artificial intelligence algorithms, user-experience enhancements and integration of new biosensor technologies. Looking ahead, DarioHealth is focused on scaling its platform globally and advancing its offerings through evidence-based studies and expanded provider networks.
